News

Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Feeling “off” turned into a critical situation within moments when Stacee suffered a ruptured brain aneurysm that led to a hemorrhagic stroke.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

An elementary school music teacher and jazz musician, 54-year-old Lisa was initially diagnosed with high blood pressure—the number one killer of women—in her early 30s. It is often called “the silent killer” because most who have it don’t experience any symptoms. Lisa was on blood pressure medication but had stopped taking it because she experienced side effects. She put off seeing her doctor about it for several months.

When Dale Cooksey's mitral valve wasn't sealing normally, doctors at Saint Luke's Mid America Heart Institute performed the MitraClip procedure to get the 98-year-old back to his active lifestyle quickly.

Saint Luke’s dedication to research means more patients have alternatives to care—like Hilda Lankard and Agnes Lickteig.